Current Edition

drug development

Patient Engagement and Real-World Data Drive Innovation in Orphan Disease Drug Development

An estimated one in 10 people are affected by a rare disease, and the cumulative economic burden of rare diseases surpasses that of common conditions …

Continue Reading →

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

The New Global Rare Disease Center of Emmes Expects Accelerating Growth from US and European Biotechs 03rd November, 2021, Rockville, Maryland (USA): Emmes – a full service, global …

Continue Reading →

CRF Health’s TrialMax Touch® Selected by Leading Specialty Pharmaceutical Company for Pediatric Rare Disease Phase II Study

CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has been selected by a leading specialty …

Continue Reading →